Last $24.90 USD
Change Today +0.13 / 0.52%
Volume 13.6K
AIQ On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 2:28 PM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

alliance healthcare service (AIQ) Snapshot

Open
$24.57
Previous Close
$24.77
Day High
$25.16
Day Low
$24.47
52 Week High
03/28/14 - $35.40
52 Week Low
12/9/13 - $20.06
Market Cap
267.2M
Average Volume 10 Days
27.3K
EPS TTM
$1.21
Shares Outstanding
10.7M
EX-Date
--
P/E TM
20.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for ALLIANCE HEALTHCARE SERVICE (AIQ)

Related News

No related news articles were found.

alliance healthcare service (AIQ) Related Businessweek News

No Related Businessweek News Found

alliance healthcare service (AIQ) Details

Alliance HealthCare Services, Inc., together with its subsidiaries, provides outpatient diagnostic imaging and radiation therapy services in the United States. The company operates through Imaging and Radiation Oncology segments. Its diagnostic imaging services include magnetic resonance imaging (MRI) technology and positron emission tomography/computed tomography (PET/CT) that generate representations of the internal anatomy and convert them to film or digital media; nuclear medicine or gamma camera, ultrasound, mammography, bone densitometry, general X-Ray technologies; and non scan-based services. The company also offers radiation oncology services, such as conventional beam therapy, 3-D conformal radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, stereotactic radiosurgery and stereotactic body radiotherapy, and low dose rate and high dose rate brachytherapy for the treatment of cancer. In addition, it provides ancillary services, such as marketing support, education, training, and billing assistance. The company offers imaging and therapeutic services to hospitals and other healthcare providers on a shared-service and full-time service basis, as well as provides services through fixed-sites, primarily to hospitals or health systems. As of December 31, 2013, Alliance HealthCare Services, Inc. had 449 diagnostic imaging and 42 radiation oncology systems, including 263 MRI systems, 122 PET or PET/CT systems, 22 CT systems, 9 ultrasound systems, and 33 other imaging systems, as well as operated 125 fixed-site imaging centers, and 28 radiation oncology centers and stereotactic radiosurgery facilities. Alliance HealthCare Services, Inc. was founded in 1983 and is headquartered in Newport Beach, California.

1,504 Employees
Last Reported Date: 03/13/14
Founded in 1983

alliance healthcare service (AIQ) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $434.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $349.8K
President of Alliance Radiology
Total Annual Compensation: $356.3K
Executive Vice President, General Counsel and...
Total Annual Compensation: $385.9K
Compensation as of Fiscal Year 2013.

alliance healthcare service (AIQ) Key Developments

Alliance Reportedly Seeks Buyers

Alliance Healthcare Services, Inc. (NasdaqGM:AIQ) is exploring a potential sale of its stake, according to people familiar with the matter. Alliance Healthcare has engaged investment bank Moelis & Co. (MC) to assist the process, the people said, asking not to be named because the matter is not public. According to Reuters, representatives for Alliance did not immediately respond to requests for comment, while a Moelis spokesperson declined to comment.

Alliance Healthcare Services, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Reports Impairment Charges for the Second Quarter of 2014; Provides Capital Expenditure Guidance for the Third Quarter of 2014; Provides Earnings Guidance for the Full Year 2014

Alliance Healthcare Services, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenues of $111,238,000 compared to $114,418,000 a year ago. This decrease was primarily due to the sale of Professional Radiology Services business line in December 2013, and pruning of unprofitable business in Radiology Division, which impacted the total by $3.8 million. Income before income taxes, earnings from unconsolidated investees, and non controlling interest was $7,380,000 compared to loss before income taxes, earnings from unconsolidated investees, and non controlling interest of $18,058,000 a year ago. Net income attributable to company was $2,784,000 or $0.26 per diluted share compared to net loss attributable to company of $12,964,000 or $1.22 per basic and diluted share a year ago. Adjusted EBITDA was $36,551,000 compared to $38,585,000 a year ago. Cash flows provided by operating activities totaled $23.9 million in the second quarter of 2014 compared to $22.0 million in the second quarter of 2013. In the second quarter of 2014, capital expenditures were $7.5 million compared to $4.8 million in the second quarter of 2013. For the six months period, the company reported revenues of $216,603,000 compared to $224,800,000 a year ago. Income before income taxes, earnings from unconsolidated investees, and noncontrolling interest was $12,869,000 compared to loss before income taxes, earnings from unconsolidated investees, and noncontrolling interest of $19,518,000 a year ago. Net income attributable to company was $4,715,000 or $0.43 per diluted share compared to net loss attributable to company of $15,382,000 or $1.45 per basic and diluted share a year ago. Net cash provided by operating activities was $42,844,000 compared to $32,513,000 a year ago. Equipment purchases were $13,256,000 compared to $10,357,000 a year ago. Adjusted EBITDA was $69,621,000 compared to $73,746,000 a year ago. Net debt, defined as total long-term debt (including current maturities), less cash and cash equivalents, decreased $18.3 million to $476.7 million at June 30, 2014 from $495.0 million at December 31, 2013. The company reported impairment charges of $236,000 for the second quarter of 2014 compared to $4,867,000 a year ago. For the third quarter 2014, the company expects MUSC Radiation Oncology project to incur approximately $11 million of CapEx. The company provided earnings guidance for the full year 2014. For the full year, the company expects net income of $20 million to $28 million and depreciation expense; amortization expense; interest expense and other, net; noncontrolling interest in subsidiaries; share-based payment and other expenses of $105 million to $115 million and adjusted EBITDA of $140 million to $160 million. Revenue expects to be $437 million to $462 million, adjusted EBITDA to be $140 million to $160 million and capital expenditures expects to be $52 million to $62 million. The free cash flow guidance range is a range of - from $27 million to $37 million. Impacting 2014 free cash flow guidance range, cash income tax payments for full year 2014, of $14 million to $17 million, which increased from $2 million of cash income taxes paid in 2013.

Alliance Healthcare Services, Inc. to Report Q2, 2014 Results on Aug 07, 2014

Alliance Healthcare Services, Inc. announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Aug 07, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AIQ:US $24.90 USD +0.13

AIQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Reference Laboratories Inc $28.04 USD -0.21
HealthSouth Corp $37.86 USD -0.42
Hill-Rom Holdings Inc $42.63 USD -0.69
RadNet Inc $6.83 USD -0.17
Stericycle Inc $115.61 USD -0.89
View Industry Companies
 

Industry Analysis

AIQ

Industry Average

Valuation AIQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book NM Not Meaningful
Price/Cash Flow 3.8x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLIANCE HEALTHCARE SERVICE, please visit www.alliancehealthcareservices-us.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.